Protagenic Therapeutics, Inc.new (PTIX) Cash & Equivalents (2009 - 2026)
Protagenic Therapeutics, Inc.new (PTIX) reported Cash & Equivalents of $76,909 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 97.2% from $2.72 million a year earlier and down 86.4% from the prior quarter.
Protagenic Therapeutics, Inc.new (PTIX) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.new posted Cash & Equivalents of $1.51 million.
- Cash & Equivalents has a five-year compound annual growth rate of 22.8% (FY2021 to FY2026).
- By fiscal year, Cash & Equivalents came in at $14,531 in FY2025, $79,568 in FY2024 (-93.8%), $1.29 million in FY2023 (+498.5%) and $215,189 in FY2022 (-60.2%).
- The fiscal Q2 2027 figure ranks as the lowest quarterly Cash & Equivalents since fiscal Q4 2025.
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $565,985 (Q1 2027), $1.51 million (Q4 2026) and $2.21 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -4.70 Mn | - | 310,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 76,909.00 |
| Jun 30, 2026 | 565,985.00 |
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 14,531.00 |
| Dec 31, 2024 | 79,568.00 |
| Sep 30, 2024 | 71,396.00 |
| Jun 30, 2024 | 924,596.00 |
| Mar 31, 2024 | 1,625.00 |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 153,332.00 |
| Jun 30, 2023 | 219,435.00 |
| Mar 31, 2023 | 138,491.00 |
| Dec 31, 2022 | 215,189.00 |
| Sep 30, 2022 | 158,323.00 |
| Jun 30, 2022 | 338,666.00 |
| Mar 31, 2022 | 482,175.00 |
| Dec 31, 2021 | 541,171.00 |
| Sep 30, 2021 | 460,115.00 |
Protagenic Therapeutics, Inc.new Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();